At Liv Hospital, dengue diagnosis and evaluation are performed with early detection, advanced lab tests, and expert clinical care.
Send us all your questions or requests, and our expert team will assist you.
Dengue Diagnosis and Evaluation
The diagnosis and evaluation of dengue fever is a critical step in ensuring timely treatment and preventing complications, especially for international patients who may be unfamiliar with local healthcare protocols. Each year, an estimated 100 million people worldwide contract dengue, and early identification can reduce the risk of severe disease by up to 90 %.
This page is designed for patients, caregivers, and healthcare professionals seeking a clear, evidence‑based overview of how dengue is diagnosed and evaluated at Liv Hospital. We will walk you through the clinical presentation, laboratory investigations, imaging options, severity grading, and the follow‑up process that together form a comprehensive diagnostic pathway.
Whether you are planning a medical visit to Istanbul or simply want to understand what to expect during a dengue work‑up, the information below reflects the standards of care practiced by our JCI‑accredited team of infectious disease specialists.
Clinical Presentation and Initial Assessment
Effective diagnosis and evaluation begins with a thorough clinical history and physical examination. Dengue often presents with a sudden high fever, severe headache, retro‑orbital pain, and myalgia—symptoms that have earned it the nickname “break‑bone fever.”
Key elements of the initial assessment include:
Physicians at Liv Hospital use a standardized checklist to capture these data, allowing rapid identification of patients who meet the clinical case definition for dengue. This systematic approach also helps differentiate dengue from other febrile illnesses such as malaria, chikungunya, or Zika virus infection.
During the physical exam, clinicians look for:
Finding | Clinical Significance
|
|---|---|
Maculopapular rash | Typical of the convalescent phase |
Positive tourniquet test | Indicates capillary fragility |
Hepatomegaly | May suggest severe disease |
Bleeding gums or petechiae | Warning sign for hemorrhagic complications |
These observations guide the next steps in the diagnosis and evaluation workflow, ensuring that laboratory testing is targeted and timely.
Laboratory Tests for Dengue Diagnosis
Laboratory confirmation is essential for definitive diagnosis and evaluation of dengue infection. The timing of specimen collection relative to symptom onset determines which tests provide the most reliable information.
Primary laboratory modalities include:
At Liv Hospital, blood samples are processed in an on‑site accredited laboratory, guaranteeing a turnaround time of less than 24 hours for NS1 and RT‑PCR. The CBC is repeated daily for patients at risk of severe dengue, allowing clinicians to detect the critical window of plasma leakage.
Interpretation of results follows internationally recognized algorithms. For example, a positive NS1 combined with a falling platelet count (<100 × 10⁹/L) and rising hematocrit (>20 % from baseline) signals the need for intensified monitoring.
Imaging and Ancillary Studies
While dengue is primarily a clinical and laboratory diagnosis, imaging plays a supportive role in the diagnosis and evaluation of complications such as plasma leakage, organ involvement, or severe hemorrhage.
Common imaging modalities include:
Liv Hospital’s radiology department employs portable ultrasound units at the bedside, enabling real‑time assessment without delaying care. A typical imaging protocol for a patient with warning signs includes a focused abdominal ultrasound on day 3–5 of illness, followed by repeat scans if clinical status worsens.
These ancillary studies complement laboratory data, providing a more comprehensive picture of disease severity and guiding decisions about fluid management, transfusion, or intensive care admission.
Differential Diagnosis and Evaluation of Severity
Accurate diagnosis and evaluation requires distinguishing dengue from other tropical infections and assessing the risk of progression to severe disease. The World Health Organization (WHO) classifies dengue into dengue without warning signs, dengue with warning signs, and severe dengue.
Key differential diagnoses to consider:
Severity evaluation relies on a combination of clinical warning signs and laboratory thresholds. The following table summarizes the WHO warning signs used at Liv Hospital:
Warning Sign | Clinical Relevance
|
|---|---|
Abdominal pain or tenderness | Indicative of plasma leakage |
Persistent vomiting | Risk of dehydration |
Rapid rise in hematocrit with falling platelets | Marker of hemoconcentration |
Bleeding gums, nosebleeds, or easy bruising | Suggests coagulopathy |
Clinical fluid accumulation (ascites, pleural effusion) | Sign of severe plasma leakage |
Lethargy or restlessness | Potential neurological involvement |
Patients exhibiting any of these signs are escalated to a higher level of care, often involving intravenous fluid therapy, close hemodynamic monitoring, and, when necessary, transfer to an intensive care unit.
Monitoring, Follow‑Up, and Prognostic Indicators
Continuous diagnosis and evaluation does not end with the initial work‑up; vigilant monitoring throughout the disease course is essential for optimal outcomes. The critical phase typically occurs between days 3 and 7, when plasma leakage peaks.
Monitoring protocol at Liv Hospital includes:
Prognostic indicators that influence discharge planning are:
Patients meeting these criteria are typically observed for an additional 24 hours before discharge, with clear instructions for home monitoring and a scheduled follow‑up visit within 7 days. Liv Hospital’s international patient services coordinate post‑discharge tele‑consultations, ensuring continuity of care for travelers returning to their home countries.
Why Choose Liv Hospital
Liv Hospital offers a JCI‑accredited environment where infectious disease specialists, laboratory scientists, and radiologists collaborate to deliver precise diagnosis and evaluation of dengue. International patients benefit from dedicated coordinators who handle appointments, transportation, interpreter services, and comfortable accommodation, allowing you to focus solely on recovery.
Send us all your questions or requests, and our expert team will assist you.
At Liv Hospital clinicians first evaluate the patient’s history, travel exposure, fever pattern and physical signs such as rash or bleeding. Blood is drawn for NS1 antigen detection within the first week, RT‑PCR for viral RNA, and IgM/IgG serology after day five. A complete blood count monitors platelet trends and hematocrit. If warning signs appear, bedside ultrasound or chest X‑ray is added to detect plasma leakage. All results are interpreted using WHO algorithms to confirm dengue and assess severity.
NS1 antigen can be detected from day 1 to day 7 and provides rapid, highly specific results. RT‑PCR confirms viral RNA, especially useful early in infection. IgM antibodies appear after day five, while IgG indicates past infection or secondary exposure. The CBC tracks platelet count, hematocrit rise, and leukopenia, which are critical for identifying the critical phase and guiding fluid management. Liv Hospital processes NS1 and RT‑PCR within 24 hours.
Portable bedside ultrasound detects pleural effusion, ascites, and gallbladder wall edema—early markers of severe dengue. Chest X‑ray evaluates pulmonary infiltrates or effusions if respiratory symptoms develop. CT scanning is reserved for suspected intracranial hemorrhage or severe abdominal pain. Liv Hospital follows a protocol of a focused abdominal ultrasound on days 3–5, repeating if the clinical picture worsens.
The WHO identifies several warning signs that prompt escalation of care: severe abdominal pain or tenderness, persistent vomiting, a rapid increase in hematocrit concurrent with a drop in platelet count, mucosal bleeding (gums, nose), clinical fluid accumulation such as ascites or pleural effusion, and lethargy or restlessness indicating possible neurological involvement. Liv Hospital monitors these signs closely and moves patients to higher‑level care when they appear.
During days 3–7, the critical phase, Liv Hospital checks CBC twice daily to track platelet count and hematocrit, measures vital signs hourly for those with warning signs, and records fluid input/output to avoid hypovolemia or overload. A repeat ultrasound on day 5 evaluates for new effusions. If platelet counts recover above 150 × 10⁹/L, hematocrit stabilizes, and warning signs resolve, patients are observed for an additional 24 hours before discharge, with tele‑consult follow‑up arranged for international travelers.
International patients benefit from a dedicated coordination team that handles visa and travel logistics, airport transfers, and language interpretation. Comfortable lodging options near the hospital are arranged, allowing patients to focus on recovery. After discharge, the hospital offers tele‑consultations and remote monitoring to ensure continuity of care once the patient returns to their home country.
Patients are eligible for discharge after meeting three criteria: platelet count recovery above 150 × 10⁹/L, hematocrit within 5 % of baseline, and complete resolution of warning signs such as bleeding, fluid accumulation, or severe abdominal pain. Before leaving, they receive education on home monitoring, a 24‑hour observation period, and a scheduled follow‑up visit within seven days, often conducted via tele‑medicine for travelers.
Your Comparison List (you must select at least 2 packages)
